secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K/A
Filed at:   2024-11-21T23:59:59+00:00
Accession:  0001493152-24-047189
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen Therapeutics appoints Graydon Bensler as independent director and audit committee chair
--------------------------------------------------------------------------------

- Bensler appointed to Board effective Nov 7, 2024; named audit committee chair on Nov 21.
- Director Agreement provides $5,000 monthly base fee plus eligibility for equity awards and indemnification.
- Bensler is independent under Nasdaq rules; amendment corrects prior 8-K with proper agreement.
- Appointment fills Board vacancy and strengthens audit committee oversight.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000149315224047189/0001493152-24-047189-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000149315224047189/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-047189

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer